Cognitiva Review

There has been considerable interest in the ADHD community  Cognitiva Review   in the use of a non-stimulant medicine for the treatment of ADHD. The most commonly prescribed non stimulant medication in the United States is Atomoxetine (Strattera). Anecdotal reports and scientific journals report that Atomoxetine works very well in some patients and not at all in others. Most of the scientific studies done on Atomoxetine have found that it works about as well as short acting stimulants but not nearly as well as the long acting or sustained release stimulants. As more research studies are completed a clearer picture has emerged of when Atomoxetine is most helpful. The findings from these studies report that Atomoxetine is probably most useful in:

Atomoxetine was helpful for treating hyperactivity, inattention, and impulsive symptoms but was not helpful for the treatment of co-morbid Oppositional Defiance Disorder (ODD). In families, the treatment of co-morbidities such as ODD is as important as the treatment of the core symptoms of ADHD. The percentage of individuals with co-morbid Oppositional symptoms in combined type ADHD and Hyperactive/Impulsive ADHD is amazingly high. One study found that more than 50% of patients with the combined type of ADHD had oppositional symptoms. That same study reported that greater than 40 percent of patients with hyperactive/impulsive ADHD exhibited symptoms of ODD. If you have ever lived with an individual with ODD you will understand how disruptive these symptoms are to a healthy family dynamic. Most adults and families would consider Atomoxetine to be an ADHD treatment failure if the symptoms of ODD were not improved while taking a medication.
 

https://supplementdevotee.com/cognitiva-review/